The Hildebrand Pain Lab was founded in 2013 by Dr. Mike Hildebrand, a principal investigator at Carleton University. Dr. Hildebrand’s translational pain research program is addressing the urgent need for safe and effective new treatments for chronic pain.  A necessary first step in this process is to identify what goes wrong at a molecular level in the spinal cord to drive chronic pain, using male and female rodent models of pain.  A huge and often overlooked next step is to answer whether these same pathological mechanisms drive increased pain signaling in the human spinal cord. The Hildebrand Pain Lab is combining rodent and human spinal pain models with a range of experimental approaches to bridge this therapeutic divide and potentially unlock the foundations for future target-based treatments for pain.